Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.06251 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.98885 | 66 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.28062 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.77042 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.89162 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.96767 | 65 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.03931 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.99999 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.95304 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.97608 | 66 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.97285 | 66 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.89884 | 65 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.0984 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.9933 | 66 |